XG7U.L vs. XGEN.DE
Compare and contrast key facts about Xtrackers Global Inflation-Linked Bond UCITS ETF 2C USD hedged (XG7U.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE).
XG7U.L and XGEN.DE are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. XG7U.L is a passively managed fund by Xtrackers that tracks the performance of the Bloomberg Gbl Infl Linked TR Hdg USD. It was launched on Feb 6, 2013. XGEN.DE is a passively managed fund by Xtrackers that tracks the performance of the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100. It was launched on Jul 12, 2022. Both XG7U.L and XGEN.DE are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
XG7U.L vs. XGEN.DE - Performance Comparison
Loading graphics...
XG7U.L vs. XGEN.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
XG7U.L Xtrackers Global Inflation-Linked Bond UCITS ETF 2C USD hedged | 0.80% | 4.67% | -0.45% | 4.13% | -5.22% |
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | -5.38% | 21.23% | -2.93% | -2.86% | -5.79% |
Different Trading Currencies
XG7U.L is traded in USD, while XGEN.DE is traded in EUR. To make them comparable, the XGEN.DE values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, XG7U.L achieves a 0.80% return, which is significantly higher than XGEN.DE's -5.38% return.
XG7U.L
- 1D
- 0.07%
- 1M
- -1.68%
- YTD
- 0.80%
- 6M
- 1.59%
- 1Y
- 3.19%
- 3Y*
- 1.87%
- 5Y*
- -0.49%
- 10Y*
- 2.09%
XGEN.DE
- 1D
- 2.65%
- 1M
- -2.71%
- YTD
- -5.38%
- 6M
- 3.93%
- 1Y
- 20.18%
- 3Y*
- 2.96%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
XG7U.L vs. XGEN.DE - Expense Ratio Comparison
XG7U.L has a 0.25% expense ratio, which is lower than XGEN.DE's 0.30% expense ratio.
Return for Risk
XG7U.L vs. XGEN.DE — Risk / Return Rank
XG7U.L
XGEN.DE
XG7U.L vs. XGEN.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers Global Inflation-Linked Bond UCITS ETF 2C USD hedged (XG7U.L) and Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XG7U.L | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.56 | 0.94 | -0.37 |
Sortino ratioReturn per unit of downside risk | 0.80 | 1.35 | -0.55 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.18 | -0.07 |
Calmar ratioReturn relative to maximum drawdown | 1.05 | 1.37 | -0.32 |
Martin ratioReturn relative to average drawdown | 3.65 | 4.45 | -0.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| XG7U.L | XGEN.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.56 | 0.94 | -0.37 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.06 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.30 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.03 | +0.30 |
Correlation
The correlation between XG7U.L and XGEN.DE is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
XG7U.L vs. XGEN.DE - Dividend Comparison
Neither XG7U.L nor XGEN.DE has paid dividends to shareholders.
Drawdowns
XG7U.L vs. XGEN.DE - Drawdown Comparison
The maximum XG7U.L drawdown since its inception was -23.33%, smaller than the maximum XGEN.DE drawdown of -33.22%. Use the drawdown chart below to compare losses from any high point for XG7U.L and XGEN.DE.
Loading graphics...
Drawdown Indicators
| XG7U.L | XGEN.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -23.33% | -37.58% | +14.25% |
Max Drawdown (1Y)Largest decline over 1 year | -3.38% | -14.88% | +11.50% |
Max Drawdown (5Y)Largest decline over 5 years | -23.33% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -23.33% | — | — |
Current DrawdownCurrent decline from peak | -11.04% | -17.22% | +6.18% |
Average DrawdownAverage peak-to-trough decline | -6.11% | -19.46% | +13.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.97% | 4.61% | -3.64% |
Volatility
XG7U.L vs. XGEN.DE - Volatility Comparison
The current volatility for Xtrackers Global Inflation-Linked Bond UCITS ETF 2C USD hedged (XG7U.L) is 1.94%, while Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) has a volatility of 7.04%. This indicates that XG7U.L experiences smaller price fluctuations and is considered to be less risky than XGEN.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| XG7U.L | XGEN.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.94% | 7.04% | -5.10% |
Volatility (6M)Calculated over the trailing 6-month period | 3.71% | 13.75% | -10.04% |
Volatility (1Y)Calculated over the trailing 1-year period | 5.65% | 21.45% | -15.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 7.76% | 19.83% | -12.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 6.99% | 19.83% | -12.84% |